The IGF-1 level in the brain can also be increased to improve the metabolic processes and restore the CNS functions in MS and T2DM, but the available data on application of this approach refer only to experimental models of T1DM [130,131]. The gene discussed is IGF1; the disease is type 2 diabetes mellitus.